Melanie Daniel: Exploring Bleeding Complications in Patients with LVADs
Melanie Daniel, Physician at Lille University Hospital, shared Inserm UMR 1011 – Hemostasis and Cardiovascular Flow’s post on LinkedIn adding:
“Interesting work in Journal of Thrombosis and Haemostasis (JTH) from our team exploring bleeding complications in patients with left ventricular assist devices (LVADs).
The study highlights the rapid degradation of von Willebrand factor activity in the LVAD setting, illustrating the challenges of restoring hemostasis in these patients.
Congratulations to the authors and collaborators.”
Inserm UMR 1011 – Hemostasis and Cardiovascular Flow shared a post on LinkedIn:
“A new study from our team, led by Prof. Antoine Rauch and Prof. Sophie Susen, explores strategies to prevent bleeding complications in patients supported with left ventricular assist devices (LVADs).
LVADs improve survival in advanced heart failure but are frequently associated with bleeding complications, partly due to the degradation of von Willebrand factor (VWF) under high shear stress.
In this multicenter randomized clinical trial, we investigated whether prophylactic administration of a purified VWF concentrate could reduce bleeding events in LVAD patients.
While VWF prophylaxis showed a trend toward reduced bleeding, pharmacokinetic analyses revealed rapid degradation of VWF in the LVAD setting, limiting the duration of its hemostatic effect.
These findings highlight the challenges of managing bleeding in mechanical circulatory support and the need for new therapeutic strategies.”
Title: Prevention of hemorrhage after implantation of mechanical circulatory support with a purified von Willebrand factor concentrate: results of the early terminated randomized controlled trial
Authors: Antoine Rauch, Guillaume Lebreton, Mouhamed D. Moussa, André Vincentelli, Erwan Flecher, Olivier Bouchot, Camille Dambrin, Laurent Barandon, Bertrand Rozec, Emmanuelle Jeanpierre, Nadine Ajzenberg, Yohann Repessé, Emmanuel De Maistre, Elodie Boissier, David M. Smadja, Mathieu Fiore, Fabienne Nedelec, Sophie Voisin, Peter J. Lenting, Silvy Laporte, Julien Labreuche, Sophie Susen
Read the Full Article on Journal of Thrombosis and Haemostasis
Stay updated with Hemostasis Today.
-
Apr 18, 2026, 10:58Jean Jacques Kiladjian: Honored to Join the HST EHA Session at the Taiwan Annual Meeting
-
Apr 18, 2026, 10:49Advancing Diagnosis to Improve Lives in Hemophilia – WFH
-
Apr 18, 2026, 10:40Akshat Jain: Improving Treatment and Access for Patients with Bleeding Disorders
-
Apr 18, 2026, 10:24Sonia Wolf: Barts Health Presence at BSH with Multiple Presentations and Awards
-
Apr 18, 2026, 10:22Cathy Harrison: The Central Role of Diagnosis in Bleeding Disorders Management
-
Apr 18, 2026, 10:10Rich Gorman: Understanding Lived Experience in Bleeding Disorders Through Arts-Based Research
-
Apr 18, 2026, 09:45Wolfgang Miesbach: Therapeutic Potential of Protein S Inhibition in Glanzmann Thrombasthenia
-
Apr 18, 2026, 00:44Join leading experts for an evening symposium at the ASPHO Conference – ISTH
-
Apr 17, 2026, 17:41José Antonio García Erce: Hematology in 48 Hours – Advancing Clinical Practice Through Expert Insight